Greenstein et al 1 report a signi®cant correlation between the number of coronary vessels occluded on angiography and erectile dysfunction (ED). This is an important ®nding because previous links between ischaemic heart disease (IHD) and ED have been largely restricted to demonstrating that these conditions share common risk factors (for example, smoking, dyslipidaemia, diabetes and hypertension).
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2 ± 4 In addition, some of the drugs (for example anti-hypertensives) used to treat IHD can cause ED. If the pathogenesis of IHD and ED is similar, then other predictors of vascular events should be shared by both these conditions. We therefore assessed plasma ®brinogen concentrations in men with ED and in matched controls. Our results reveal higher levels of this coagulation factor in those with ED. 4 We are currently evaluating lipoprotein (a) levels in men with ED. This lipoprotein is another predictor of a variety of vascular events (for example, myocardial infarction and stroke). These studies would support the routine screening of patients with vasculogenic ED for cardiovascular risk factors.
Good diabetic and blood pressure control are well recognised therapies, but current evidence also raises the question of early intervention with lipidlowering agents (some of which are known to reduce ®brinogen levels). Support for such an approach comes from several studies, 5, 6 which showed a signi®cant reduction in cardiovascular events and a reduction in the progression of coronary atheromatous lesions in patients with hypercholesterolaemia taking lipid-lowering therapy (for example 4S 5 and MAAS 6 ). Finally, medical practitioners who treat patients with ED should be aware of potential underlying IHD and its clinical relevance in terms of`whole patient management.' 
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